LivingGLP1
Study S001303

Post-marketing Surveillance (Special Use-results Surveillance) on Use With Liraglutide (Victoza®)

ClinicalTrials.gov record

Registration

Registration
NCT02321878
Study type
OBSERVATIONAL
Status
COMPLETED
Enrollment
1092
Start
2014-12-15
Primary completion
2017-06-16
Lead sponsor
Novo Nordisk A/S
Conditions
Diabetes; Diabetes Mellitus, Type 2
Interventions
DRUG:liraglutide
Results posted
FALSE
Secondary identifiers
OTHER:U1111-1157-6701

Registered primary outcomes

  • Number of AEs (adverse events) [Week 0-52]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.